Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_assertion type Assertion NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_head.
- NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_assertion description "[At the lowest doses, the TGFbeta-RII-mutated and KRAS2-mutated cell line, TOV-21G, and the BRCA2-mutated cell line, TOV-81D, demonstrated a significantly higher sensitivity to cisplatin and gamma-irradiation than the TP53-mutated cell lines, TOV-112D and OV-90.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_provenance.
- NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_assertion evidence source_evidence_literature NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_provenance.
- NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_assertion SIO_000772 15258697 NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_provenance.
- NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_assertion wasDerivedFrom befree-20140225 NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_provenance.
- NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_assertion wasGeneratedBy ECO_0000203 NP703143.RAZFnUODF2Jy-dHnLsY7So6b3QlZWqK2BY4kxaMMKiI4M130_provenance.